Anti-Klebsiella pneumoniae mrkA Antibody (SAA2657) from ProteoGenix; catalogue ARO-A23089; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Klebsiella pneumoniae mrkA antibody is a monoclonal antibody targeting fimbrial subunit type 3 (mrkA), a major structural component of type 3 fimbriae in Klebsiella pneumoniae. This protein plays a key role in bacterial adhesion and biofilm formation, making it an important target for studies investigating bacterial pathogenicity and host-pathogen interactions.
This Klebsiella pneumoniae antibody enables researchers to detect and study mrkA expression in microbiology, infectious disease, and antimicrobial research.
mrkA is the primary structural protein of type 3 fimbriae, surface appendages that contribute to bacterial attachment to host tissues and abiotic surfaces. These structures are associated with biofilm formation and virulence in Klebsiella pneumoniae infections, particularly in clinical environments.
Antibodies targeting mrkA are valuable tools for investigating bacterial colonization mechanisms, virulence factors, and pathogen-host interactions.
This anti-mrkA monoclonal antibody is suitable for research applications such as:
For research use only.
ProteoGenix catalogue number ARO-A23089.
Target: Fimbrial subunit type 3, mrkA; Clonality: Monoclonal Antibody; Applications: Block, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Block |
|---|---|---|---|---|---|---|---|---|---|
| Fimbrial subunit type 3, mrkA |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
